Yuda, J., Ishiguro, Y., Kuboki, Y., Nakatsura, T., Suzuki, T., Nakamura, H., Ikeno, T., Wakabayashi, M., Fuse, N., Sato, A., Nakamura, N., Sakoda, Y., Doi, T., Tamada, K. (2025). Phase I study to evaluate the safety and efficacy of switchable CAR-T cell therapy with FY001 and CART001 in patients with refractory CD20-positive B-cell non-Hodgkin lymphoma (EPOC1803).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.7031